Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lisa-Marie Pfeffermann"'
Autor:
Zyrafete Kuçi, Natascha Piede, Kathrin Vogelsang, Lisa-Marie Pfeffermann, Sibylle Wehner, Emilia Salzmann-Manrique, Miriam Stais, Hermann Kreyenberg, Halvard Bonig, Peter Bader, Selim Kuçi
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background According to the definition of the International Society for Cell and Gene Therapy (ISCT), mesenchymal stromal cells (MSCs) do not express HLA-DR. This phenotypic marker as a release criterion for clinical use was established at a
Externí odkaz:
https://doaj.org/article/778e9dd465974dbfb7bc2dc39a27d05c
Autor:
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa‑Marie Pfeffermann, Bernd Jahrsdörfer, Hubert Schrezenmeier, Selim Kuci, Zyrafete Kuci, Anke Zens, Michael Tribanek, Robert Zeiser, Sabine Huenecke, Peter Bader
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/b531e2a3fa18414fbe6b2e7f1a58550c
Autor:
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa-Marie Pfeffermann, Bernd Jahrsdörfer, Hubert Schrezenmeier, Selim Kuci, Zyrafete Kuci, Anke Zens, Michael Tribanek, Robert Zeiser, Sabine Huenecke, Peter Bader
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with steroid-refractory acute graft-versus-host disease (aGvHD) not tolerating/responding to ruxolitinib (RR-aGvHD) have a dismal prognosis. Methods We retrospectively assessed real-world outcomes of RR-aGvHD treated with
Externí odkaz:
https://doaj.org/article/1942e01c115d422bbf46c4611ede54dd
Autor:
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel, Halvard Bonig, Theres Fingerhut, Laura Puth, Kathrin Vogelsang, Andreas Peinelt, Rolf Marschalek, Matthias Müller, Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke
Publikováno v:
Cells, Vol 12, Iss 6, p 850 (2023)
Mesenchymal stromal cells (MSCs) have the potential to suppress pathological activation of immune cells and have therefore been considered for the treatment of Graft-versus-Host-Disease. The clinical application of MSCs requires a process validation
Externí odkaz:
https://doaj.org/article/a7c755e7cf274e35b8578d2834c3ce95
Autor:
Ruth Duecker, Patrick C. Baer, Aileen Buecker, Sabine Huenecke, Lisa-Marie Pfeffermann, Ute Modlich, Shahrzad Bakhtiar, Peter Bader, Stefan Zielen, Ralf Schubert
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Ataxia-telangiectasia (A-T) is a multisystem disorder with progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and increased cancer susceptibility. Cellular immunodeficiency is based on naïve CD4+ and CD8+ T-cell ly
Externí odkaz:
https://doaj.org/article/e8754e915039445e99bd174d0002e63f
Autor:
Leonie D. H. Gossel, Catrin Heim, Lisa-Marie Pfeffermann, Laura M. Moser, Halvard B. Bönig, Thomas E. Klingebiel, Peter Bader, Winfried S. Wels, Michael Merker, Eva Rettinger
Publikováno v:
Cancers, Vol 13, Iss 6, p 1443 (2021)
The dismal prognosis of pediatric and young adult patients with high-risk rhabdomyosarcoma (RMS) underscores the need for novel treatment options for this patient group. In previous studies, the tumor-associated surface antigen ERBB2 (HER2/neu) was i
Externí odkaz:
https://doaj.org/article/2c7b8ab2be7c4ea6903979c671eee640
Autor:
Melanie Bremm, Lisa-Marie Pfeffermann, Claudia Cappel, Verena Katzki, Stephanie Erben, Sibille Betz, Andrea Quaiser, Michael Merker, Halvard Bonig, Michael Schmidt, Thomas Klingebiel, Peter Bader, Sabine Huenecke, Eva Rettinger
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administra
Externí odkaz:
https://doaj.org/article/2b410e20b4ca4cdc83f38cb8aef2ef96
Autor:
Zyrafete Kuҫi, Christiane Jordan, Sibylle Wehner, Jan Sörensen, Andrea Jarisch, Emilia Salzmann-Manrique, Lisa-Marie Pfeffermann, Thomas Klingebiel, Peter Bader, Selim Kuҫi
Publikováno v:
Cells, Vol 9, Iss 2, p 431 (2020)
As the biology of mesenchymal stromal cells (MSCs) in patients with non-malignant hematological diseases (NMHD) is poorly understood, in the current study we performed a basic characterization of the phenotype and functional activity of NMHD-MSCs. Bo
Externí odkaz:
https://doaj.org/article/6432bdc507ea43d68b23340bfbe5be30
Autor:
Christina Karantanou, Valentina R. Minciacchi, Rahul Kumar, Costanza Zanetti, Jimena Bravo, Raquel S. Pereira, Georg Tascher, Tobias Tertel, Adriana Covarrubias-Pinto, Katrin Bankov, Lisa-Marie Pfeffermann, Halvard Bonig, Paola Divieti-Pajevic, David G. McEwan, Bernd Giebel, Christian Münch, Ivan Dikic, Daniela S. Krause
Publikováno v:
Blood Advances. 7:1190-1203
Leukemia cells reciprocally interact with their surrounding bone marrow microenvironment (BMM), rendering it hospitable to leukemia cell survival, for instance through the release of small extracellular vesicles (sEVs). In contrast, we show here that
Autor:
Lisa-Marie Pfeffermann, Denisa Bojkova, Joshua Kandler, Sabine Huenecke, Melanie Bremm, Natascha Piede, Selim Kuci, Zyrafete Kuci, Sabine Harenkamp, Halvard Bonig, Peter Bader
Publikováno v:
Blood. 140:12678-12679